The STEP trial program The STEP (Semaglutide Treatment Effect in People with Obesity) trials enrolled thousands of participants and tracked results over 68 weeks
Even when assumptions about costs, treatment persistence, and patient subgroups varied, tirzepatide remained either cost-saving or highly cost-effective in the model
To get approved, you usually need to meet a BMI qualification requirement and provide documentation of failed weight loss attempts through diet, exercise, or previous medications
In receptor binding studies, it has been shown to have a GLP-1R and GLP-1 binding affinity, respectively, about five times lower than that of native and similar to endogenous GIP (40)
The Wegovy BMI requirements are the same as Mounjaros